← All companies
CATALYST PHARMACEUTICALS, INC.
CPRX - CIK 0001369568
Market cap$3.84 B
Rank#1606
SEC filings1,337
The table below shows CATALYST PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $755.86M | $689.89M | $652.80M | $580.66M | $442.33M | $375.69M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $130.83M | $106.41M | $65.86M | $71.27M | $58.27M | $57.17M |
| Inventory | $34.93M | $28.03M | $18.65M | $19.78M | $20.02M | $18.01M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.